Published in Adv Urol on May 30, 2011
Organ Preservation Surgery for Carcinoma Penis. Indian J Surg Oncol (2016) 0.75
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med (2006) 25.67
Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med (2002) 10.80
History of circumcision, medical conditions, and sexual activity and risk of penile cancer. J Natl Cancer Inst (1993) 2.92
Genital tumors among men with psoriasis exposed to psoralens and ultraviolet A radiation (PUVA) and ultraviolet B radiation. The Photochemotherapy Follow-up Study. N Engl J Med (1990) 2.40
Etiology of squamous cell carcinoma of the penis. Scand J Urol Nephrol Suppl (2000) 2.23
Penile cancer: epidemiology, pathogenesis and prevention. World J Urol (2008) 2.14
Scanning with 18F-FDG-PET/CT for detection of pelvic nodal involvement in inguinal node-positive penile carcinoma. Eur Urol (2009) 1.71
Detection of human papillomavirus in squamous neoplasm of the penis. J Urol (1992) 1.68
Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol (2001) 1.67
Peniscopically controlled CO2 laser excision for conservative treatment of in situ and T1 penile carcinoma: report on 224 patients. Eur Urol (2008) 1.49
Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study. J Clin Oncol (2010) 1.49
Burden of invasive squamous cell carcinoma of the penis in the United States, 1998-2003. Cancer (2008) 1.48
Long-term followup of penile carcinoma treated with penectomy and bilateral modified inguinal lymphadenectomy. J Urol (2004) 1.48
Advanced penile carcinoma. J Urol (2003) 1.47
Regional lymph node staging using lymphotropic nanoparticle enhanced magnetic resonance imaging with ferumoxtran-10 in patients with penile cancer. J Urol (2005) 1.47
Size of metastasis in the sentinel node predicts additional nodal involvement in penile carcinoma. J Urol (2006) 1.43
Cervical papillomavirus infection and intraepithelial neoplasia: a study of male sexual partners. Obstet Gynecol (1984) 1.41
Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study. J Urol (1999) 1.39
Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma. J Urol (2007) 1.35
Squamous cell carcinoma of the penis. IV. Prognostic factors of survival: analysis of tumor, nodes and metastasis classification system. J Urol (1994) 1.32
Targeted therapies in squamous cell carcinoma of the head and neck. Cancer (2009) 1.27
Modified inguinal lymphadenectomy for carcinoma of the penis with preservation of saphenous veins: technique and preliminary results. J Urol (1988) 1.24
Epidemiology and natural history of penile cancer. Urology (2010) 1.22
EAU Guidelines on Penile Cancer. Eur Urol (2004) 1.19
Penile cancer: clinical presentation, diagnosis, and staging. Urol Clin North Am (2010) 1.13
Two-center evaluation of dynamic sentinel node biopsy for squamous cell carcinoma of the penis. J Clin Oncol (2009) 1.11
Human papillomavirus vaccination in males. Gynecol Oncol (2007) 1.05
The prevalence of human papillomavirus genotypes in penile cancers from northern Thailand. J Med Virol (2006) 1.05
Penile cancer: is there an epidemiological role for smoking and sexual behaviour? Br Med J (Clin Res Ed) (1987) 1.03
Management of the lymph nodes in penile cancer. Urology (2010) 1.01
Contemporary inguinal lymph node dissection: minimizing complications. World J Urol (2008) 1.00
Multimodality therapy in penile cancer: when and which treatments? World J Urol (2008) 0.99
Predicting pelvic lymph node metastases in penile cancer patients: a comparison of computed tomography, Cloquet's node, and disease burden of inguinal lymph nodes. Onkologie (2008) 0.99
Chemotherapy for penile and urethral carcinoma. Urol Clin North Am (2010) 0.98
18F-FDG PET/CT for staging of penile cancer. J Nucl Med (2005) 0.97
Laser therapy for carcinoma in situ of the penis. J Urol (2001) 0.92
Carcinoma of the penis: analysis of 219 cases. Cancer (1982) 0.91
New horizons in MR technology: RF coil designs and trends. Magn Reson Med Sci (2007) 0.91
Differential diagnosis of lymph node lesions: a semiquantitative approach with colour Doppler ultrasound. Br J Radiol (1998) 0.90
External-beam radiotherapy in T1-2 N0 penile carcinoma. Clin Oncol (R Coll Radiol) (2006) 0.89
Controversies in ilioinguinal lymphadenectomy. Urol Clin North Am (2010) 0.89
Penile preserving surgery and surgical strategies to maximize penile form and function in penile cancer: recommendations from the United Kingdom experience. World J Urol (2008) 0.89
Local staging of penile cancer using magnetic resonance imaging with pharmacologically induced penile erection. Radiol Med (2008) 0.88
Association between the intact foreskin and inferior standards of male genital hygiene behaviour: a cross-sectional study. Int J STD AIDS (2005) 0.88
Nomogram predictive of pathological inguinal lymph node involvement in patients with squamous cell carcinoma of the penis. J Urol (2006) 0.88
Penile cancer--prevention and premalignant conditions. Urology (2010) 0.88
Squamous cell carcinoma of the penis and microscopic pathologic margins: how much margin is needed for local cure? Cancer (1999) 0.87
Sentinel lymph node biopsy using dynamic lymphoscintigraphy combined with ultrasound-guided fine needle aspiration in penile carcinoma. Br J Radiol (2009) 0.86
Penile cancer. Urol Oncol (2009) 0.81
Squamous cell carcinoma of the penis. II. Treatment of the primary tumor. J Urol (1992) 0.81
Topical treatment of intraepithelial penile carcinoma with imiquimod. Clin Exp Dermatol (2003) 0.80
Erythroplasia of Queyrat. Treatment with topically applied fluorouracil. JAMA (1975) 0.79
Advances in penile cancer management. Curr Opin Oncol (2010) 0.79
Ultrasound in squamous cell carcinoma of the penis; a useful addition to clinical staging? A comparison of ultrasound with histopathology. Urology (1994) 0.78
Bowen's disease and squamous cell carcinoma. Occurrence in a patient with psoriasis after topical, systemic, and PUVA therapy. Arch Dermatol (1979) 0.78
Long-term follow-up after laser therapy for penile carcinoma. Urology (2007) 0.77
Imaging tumors of the penis and urethra. Urol Clin North Am (2010) 0.76
Controversies concerning lymph node dissection for cancer of the penis. Urol Clin North Am (1980) 0.76
Clinical and sonographic findings in carcinoma of the penis. J Clin Ultrasound (2000) 0.76
Corpus cavernosogram in the evaluation of carcinoma of the penis. J Urol (1978) 0.76
EAU penile cancer guidelines 2009. Eur Urol (2010) 3.03
Local control rate and prognosis after sequential chemoradiation for small cell carcinoma of the bladder. Int J Urol (2012) 2.76
Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol (2007) 2.68
Bladder cancer. J Natl Compr Canc Netw (2013) 2.46
Reliability and safety of current dynamic sentinel node biopsy for penile carcinoma. Eur Urol (2007) 2.44
Identification of high risk pathological node positive penile carcinoma: value of preoperative computerized tomography imaging. J Urol (2011) 2.42
P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors. Eur Urol (2007) 2.21
Anatomical mapping of lymphatic drainage in penile carcinoma with SPECT-CT: implications for the extent of inguinal lymph node dissection. Eur Urol (2008) 2.19
Carboplatin based induction chemotherapy for nonorgan confined bladder cancer--a reasonable alternative for cisplatin unfit patients? J Urol (2012) 2.14
Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle. BJU Int (2013) 2.06
Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients. Eur Urol (2008) 2.02
Neoadjuvant chemotherapy in advanced penile carcinoma. Eur Urol (2007) 1.95
The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer. Eur Urol (2011) 1.93
Important surgical considerations in the management of renal cell carcinoma (RCC) with inferior vena cava (IVC) tumour thrombus. BJU Int (2012) 1.76
Inguinal recurrence following therapeutic lymphadenectomy for node positive penile carcinoma: outcome and implications for management. J Urol (2011) 1.72
Scanning with 18F-FDG-PET/CT for detection of pelvic nodal involvement in inguinal node-positive penile carcinoma. Eur Urol (2009) 1.71
Evaluation of current TNM classification of penile carcinoma. J Urol (2008) 1.63
Prostate cancer progression in the presence of undetectable or low serum prostate-specific antigen level. Cancer (2007) 1.56
Nodal staging in penile carcinoma by dynamic sentinel node biopsy after previous therapeutic primary tumour resection. Eur Urol (2010) 1.55
Comparing the hybrid fluorescent-radioactive tracer indocyanine green-99mTc-nanocolloid with 99mTc-nanocolloid for sentinel node identification: a validation study using lymphoscintigraphy and SPECT/CT. J Nucl Med (2012) 1.53
Human papillomavirus-16 is the predominant type etiologically involved in penile squamous cell carcinoma. J Clin Oncol (2007) 1.53
Is the R.E.N.A.L. nephrometry scoring system predictive of the functional efficacy of nephron sparing surgery in the solitary kidney? J Urol (2012) 1.51
Prostate-sparing cystectomy: long-term oncological results. BJU Int (2009) 1.51
Size of metastasis in the sentinel node predicts additional nodal involvement in penile carcinoma. J Urol (2006) 1.43
Feasibility of sentinel node detection in renal cell carcinoma: a pilot study. Eur J Nucl Med Mol Imaging (2010) 1.42
Feasibility of sentinel node lymphoscintigraphy in stage I testicular cancer. Eur J Nucl Med Mol Imaging (2002) 1.42
Long-term outcome for men with teratoma found at postchemotherapy retroperitoneal lymph node dissection. Cancer (2009) 1.41
Urinary diversions after cystectomy: the association of clinical factors, complications and functional results of four different diversions. Eur Urol (2007) 1.40
Contemporary Issues Surrounding Small Renal Masses: Evaluation, Diagnostic Biopsy, Nephron Sparing, and Novel Treatment Modalities. Oncology (Williston Park) (2016) 1.38
Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma. J Urol (2007) 1.35
Visualization of tumor blockage and rerouting of lymphatic drainage in penile cancer patients by use of SPECT/CT. J Nucl Med (2009) 1.33
The growing teratoma syndrome: Current review of the literature. Indian J Urol (2009) 1.32
Mutations within the kinase domain and truncations of the epidermal growth factor receptor are rare events in bladder cancer: implications for therapy. Clin Cancer Res (2006) 1.30
Chylous ascites after post-chemotherapy retroperitoneal lymph node dissection: review of the M. D. Anderson experience. J Urol (2006) 1.27
Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC. J Clin Oncol (2008) 1.26
Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer. Urology (2005) 1.25
Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy. J Urol (2009) 1.19
Lymphadenectomy in the surgical management of penile cancer. Eur Urol (2009) 1.19
Neoadjuvant sunitinib for surgically complex advanced renal cell cancer of doubtful resectability: initial experience with downsizing to reconsider cytoreductive surgery. World J Urol (2009) 1.19
Presence of high-risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival. Int J Cancer (2006) 1.18
Prognosis of primary mucosal penile melanoma: a series of 19 Dutch patients and 47 patients from the literature. Urology (2007) 1.18
Pelvic lymph node dissection for penile carcinoma: extent of inguinal lymph node involvement as an indicator for pelvic lymph node involvement and survival. J Urol (2007) 1.15
Interobserver reliability of the RENAL nephrometry scoring system. Urology (2011) 1.14
Two-center evaluation of dynamic sentinel node biopsy for squamous cell carcinoma of the penis. J Clin Oncol (2009) 1.11
Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection. J Natl Cancer Inst (2008) 1.09
Radiofrequency ablation for treatment of sporadic angiomyolipoma. Urology (2008) 1.06
Kidney cancer. J Natl Compr Canc Netw (2011) 1.06
Surgical management of lymph-node-positive prostate cancer: improves symptomatic control. BJU Int (2010) 1.03
Primary Ewing sarcoma of the kidney: a symptomatic presentation and review of the literature. Ther Adv Urol (2013) 1.02
Pretreatment semen parameters in men with cancer. J Urol (2008) 1.02
Phase I clinical and pharmacokinetic study of kahalalide F in patients with advanced androgen refractory prostate cancer. Clin Cancer Res (2005) 1.01
Evidence for at least three alternative mechanisms targeting the p16INK4A/cyclin D/Rb pathway in penile carcinoma, one of which is mediated by high-risk human papillomavirus. J Pathol (2003) 1.01
Cytoreductive nephrectomy for T4NxM1 renal cell carcinoma: the M.D. Anderson Cancer Center experience. Urology (2007) 0.99
Long-term survival after sequential chemoradiation for limited disease small cell carcinoma of the bladder. World J Urol (2008) 0.98
Association between lymph node density and disease specific survival in patients with penile cancer. J Urol (2009) 0.98
Primary bladder preservation treatment for urothelial bladder cancer. Cancer Control (2013) 0.97
Penile cancer: Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw (2013) 0.97
Lack of BK virus DNA sequences in most transitional-cell carcinomas of the bladder. Int J Cancer (2007) 0.96
Current and emerging bladder cancer urinary biomarkers. ScientificWorldJournal (2011) 0.96
Ultrasonography-guided fine-needle aspiration cytology before sentinel node biopsy in patients with penile carcinoma. BJU Int (2005) 0.96
[Pregnancy following sexuality-preserving cystectomy for bladder carcinoma]. Ned Tijdschr Geneeskd (2011) 0.95
Penile cancer: organ-sparing techniques. BJU Int (2014) 0.95
Non-invasive and minimally invasive staging of regional lymph nodes in penile cancer. World J Urol (2008) 0.95
Prostatic urethral biopsy has limited usefulness in counseling patients regarding final urethral margin status during orthotopic neobladder reconstruction. J Urol (2008) 0.95
Patterns of outcome and toxicity after salvage prostatectomy, salvage cryosurgery and salvage brachytherapy for prostate cancer recurrences after radiation therapy: a multi-center experience and literature review. World J Urol (2012) 0.95
Management of urethral recurrence after orthotopic urinary diversion. BJU Int (2009) 0.94
Probability of downsizing primary tumors of renal cell carcinoma by targeted therapies is related to size at presentation. Urology (2012) 0.93
Hereditary causes of kidney tumours. Eur J Clin Invest (2010) 0.92
Dynamic sentinel node biopsy in penile carcinoma: evaluation of 10 years experience. Eur Urol (2005) 0.92
Peroperative transrectal ultrasonography-guided bladder neck dissection eases the learning of robot-assisted laparoscopic prostatectomy. BJU Int (2008) 0.91
Prospective clinical trial of the feasibility and safety of modified retroperitoneal lymph node dissection at time of nephroureterectomy for upper tract urothelial carcinoma. BJU Int (2012) 0.90
Value of SPECT/CT for detection and anatomic localization of sentinel lymph nodes before laparoscopic sentinel node lymphadenectomy in prostate carcinoma. J Nucl Med (2009) 0.90
A phase II study of presurgical sunitinib in patients with metastatic clear-cell renal carcinoma and the primary tumor in situ. Urology (2011) 0.90
Prognostic significance of extranodal extension in patients with pathological node positive penile carcinoma. J Urol (2010) 0.89
Current concepts in penile cancer. J Natl Compr Canc Netw (2013) 0.89
Salvage surgery for locally recurrent prostate cancer after radiation therapy: tricks of the trade. Urol Oncol (2007) 0.88
Paraaortic sentinel lymph nodes: toward optimal detection and intraoperative localization using SPECT/CT and intraoperative real-time imaging. J Nucl Med (2010) 0.87
Incidence trends and survival of penile squamous cell carcinoma in the Netherlands. Int J Cancer (2010) 0.87
Accuracy of 18F-FDG PET/CT for diagnosing inguinal lymph node involvement in penile squamous cell carcinoma: systematic review and meta-analysis of the literature. Clin Nucl Med (2012) 0.87
Challenges and potential solutions to meeting accrual goals in a Phase II chemoprevention trial for prostate cancer. Contemp Clin Trials (2011) 0.86
Surgery plus targeted therapy for renal cell carcinoma with isolated spermatic cord metastasis. Clin Genitourin Cancer (2009) 0.86
Update in the surgical principles and therapeutic outcomes of inguinal lymph node dissection for penile cancer. Urol Oncol (2011) 0.85
A phase-II study of pegylated interferon alfa-2b for patients with metastatic renal cell carcinoma and removal of the primary tumor. Cancer Immunol Immunother (2004) 0.85
Unusual complication after immediate postoperative intravesical mitomycin C instillation. Eur Urol (2003) 0.85
Accuracy of sentinel lymph node biopsy for inguinal lymph node staging of penile squamous cell carcinoma: systematic review and meta-analysis of the literature. J Urol (2011) 0.85
Long-term tensile properties of tension-free vaginal tape, suprapubic arc sling system and urethral sling in an in vivo rat model. J Urol (2007) 0.85
Predicting ease of perinephric fat dissection at time of open partial nephrectomy using preoperative fat density characteristics. BJU Int (2014) 0.84
FDG-positron emission tomography/computerized tomography for monitoring the response of pelvic lymph node metastasis to neoadjuvant chemotherapy for bladder cancer. J Urol (2012) 0.84
Early results of chemotherapy with retroperitoneal lymph node dissection for isolated retroperitoneal recurrence of upper urinary tract urothelial carcinoma after nephroureterectomy. Can J Urol (2010) 0.84
Penile cancer: incremental insights into etiology, diagnosis, staging, and management. World J Urol (2009) 0.84
Penile cancer stage, survival and body mass index. Urol Int (2015) 0.84
Laparoscopic sentinel node dissection for prostate carcinoma: technical and anatomical observations. BJU Int (2008) 0.84
Testis cancer survivors' health behaviors: comparison with age-matched relative and demographically matched population controls. J Clin Oncol (2010) 0.84
Update in the management of penile cancer. Int Braz J Urol (2009) 0.83
Infiltration of activated dendritic cells and T cells in renal cell carcinoma following combined cytokine immunotherapy. Eur Urol (2005) 0.83
Microarray gene-expression profiling to predict lymph node metastasis in penile carcinoma. BJU Int (2008) 0.83